Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)

NCT03113968 is registered in ClinicalTrials.gov with Bo Hu as lead sponsor.

NCT NCT03113968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
Lead sponsor
Bo Hu
Phase
Phase 2/3
Overall status
Completed
Start date
April 7, 2017
Completion date
November 17, 2022
Enrollment
403 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

depression, ect, electroconvulsive therapy, ketamine, major depressive disorder, major depressive episode, psychiatric disorder, treatment resistant depression, unipolar depression